[F1ANNEX I U.K. ANALYTICAL, PHARMACOTOXICOLOGICAL AND CLINICAL STANDARDS AND PROTOCOLS IN RESPECT OF THE TESTING OF MEDICINAL PRODUCTS

PART I U.K. STANDARDISED MARKETING AUTHORISATION DOSSIER REQUIREMENTS

5. MODULE 5: CLINICAL STUDY REPORTS U.K.

5.1. Format and Presentation U.K.

The general outline of Module 5 is as follows:

  • Table of contents for clinical study reports

  • Tabular listing of all clinical studies

  • Clinical study reports

    • Reports of Bio-pharmaceutical Studies

      • Bio-availability Study Reports

      • Comparative Bio-availability and Bio-equivalence Study Reports

      • In vitro — In vivo Correlation Study Report

      • Reports of Bio-analytical and Analytical Methods

    • Reports of Studies Pertinent to Pharmaco-kinetics Using Human Bio-materials

      • Plasma Protein Binding Study Reports

      • Reports of Hepatic Metabolism and Interaction Studies

      • Reports of Studies Using Other Human Bio-materials

    • Reports of Human Pharmaco-kinetic Studies

      • Healthy subjects Pharmaco-kinetics and Initial Tolerability Study Reports

      • Patient Pharmaco-kinetics and Initial Tolerability Study Reports

      • Intrinsic Factor Pharmaco-kinetics Study Reports

      • Extrinsic Factor Pharmaco-kinetics Study Reports

      • Population Pharmaco-kinetics Study Reports

    • Reports of Human Pharmaco-dynamic Studies

      • Healthy Subject Pharmaco-dynamic and Pharmaco-kinetics/Pharmaco-dynamic Study Reports

      • Patient Pharmaco-dynamic and Pharmaco-kinetics/Pharmaco-dynamic Studies Study Reports

    • Reports of Efficacy and Safety Studies

      • Study Reports of Controlled Clinical Studies Pertinent to the Claimed Indication

      • Study Reports of Uncontrolled Clinical Studies

      • Reports of Analyses of Data from More than One Study including any formal integrated analyses, meta-analyses and bridging analyses

      • Other Study Reports

    • Reports of Post-marketing Experience

  • Literature references]